Oxford Science Enterprises plc sold BRNS
September 9, 2026 · Form 4 insider transaction
Oxford Science Enterprises plc sold 8,797,770 shares of Barinthus Biotherapeutics plc at $0.11 per share, a transaction worth $976.6K. The trade was recorded as u and disclosed on an SEC Form 4, filed 2 days after the transaction.
Footnotes
Ordinary Shares may be represented by American Depositary Shares, each of which represents one Ordinary Share.; Pursuant to the terms of the Merger Agreement between Barinthus Biotherapeutics plc (the "Issuer") and Clywedog Therapeutics, Inc., the Issuer's board of directors has determined that each of the Issuer's outstanding Ordinary Shares (represented by American Depositary Shares) will be converted into the right to receive 0.111 shares of Beacon Topco, Inc.'s common stock, plus cash in lieu of any fractional shares resulting from the exchange, in accordance with the scheme of arrangement.